ID

39362

Description

Study ID: 104430 Clinical Study ID: 104430 Study Title: A phase II, double blind, randomized, controlled study to evaluate the immunogenicity, reactogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ Hib-MenAC vaccine, extemporaneously mixed with GSK Biologicals’ Tritanrix-HepB, as compared to GSK Biologicals’ Hiberix vaccine, extemporaneously mixed with GSK Biologicals’ Tritanrix-HepB, when administered intramuscularly in infants at 6, 10 and 14 weeks of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1/2 Study Recruitment Status: Completed Generic Name: Hib-MenAC vaccine Trade Name: Tritanrix-HepB, Hiberix Study Indication: Immune, Inflammatory & Infections - Other

Mots-clés

Versions (3)
  1. 25/03/2019 25/03/2019 -
  2. 31/12/2019 31/12/2019 -
  3. 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
Détendeur de droits

GSK group of companies

Téléchargé le

31 décembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Hib-MenAC vaccine administered intramuscularly in infants at 6 10 and 14 weeks of age - 104430

Anglais

Visit 5 ( Month 7.5)

1 Formulaires  
  1. StudyEvent: ODM
    1. Visit 5 ( Month 7.5)
Administrative data
Description

Administrative data

Alias
UMLS CUI-1
C1320722
Center
Description

Center

Type de données

integer

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Visit Date
Description

Visit Date

Type de données

date

Alias
UMLS CUI [1]
C1320303
Subject number
Description

Subject number

Type de données

integer

Alias
UMLS CUI [1]
C2348585
ELIMINATION CRITERIA DURING THE STUDY
Description

ELIMINATION CRITERIA DURING THE STUDY

Alias
UMLS CUI-1
C0680251
UMLS CUI-2
C0347984
UMLS CUI-3
C0008976
Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) during the study period.
Description

Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) during the study period.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C4723751
UMLS CUI [1,3]
C0304229
UMLS CUI [1,4]
C0347984
UMLS CUI [1,5]
C2347804
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C4723751
UMLS CUI [2,3]
C0304229
UMLS CUI [2,4]
C0042196
UMLS CUI [2,5]
C0347984
UMLS CUI [2,6]
C2347804
Chronic administration (defined as more than 14 days) of immunosuppressants or other immunemodifying drugs during the study period.
Description

(For corticosteroids, this will mean prednisone, or equivalent, ≥ 0.5 mg/kg/day. Inhaled and topical steroids are allowed).

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C0205191
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C2347804
UMLS CUI [2,1]
C0005525
UMLS CUI [2,2]
C0205191
UMLS CUI [2,3]
C0347984
UMLS CUI [2,4]
C2347804
UMLS CUI [3,1]
C0332300
UMLS CUI [3,2]
C2065041
UMLS CUI [4,1]
C0332300
UMLS CUI [4,2]
C2064827
Administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before the first dose of vaccine(s) and ending 30 days after the last dose of vaccine(s) with the exception of OPV.
Description

Unplanned vaccination

Type de données

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C4511973
UMLS CUI [1,4]
C2347804
UMLS CUI [1,5]
C2348563
UMLS CUI [1,6]
C4698437
UMLS CUI [2,1]
C0332300
UMLS CUI [2,2]
C0032375
Administration of a meningococcal vaccine not foreseen by the study protocol during the entire study period.
Description

Administration of a meningococcal vaccine

Type de données

boolean

Alias
UMLS CUI [1,1]
C2368628
UMLS CUI [1,2]
C0700144
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C2347804
UMLS CUI [1,5]
C2348563
UMLS CUI [1,6]
C4698437
Administration of immunoglobulins and/or any blood products during the study period.
Description

Administration of immunoglobulins and/or any blood products during the study period.

Type de données

boolean

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0021027
UMLS CUI [1,3]
C2347804
UMLS CUI [2,1]
C1533734
UMLS CUI [2,2]
C0456388
UMLS CUI [2,3]
C2347804
UMLS CUI [3,1]
C1533734
UMLS CUI [3,2]
C0456388
UMLS CUI [3,3]
C0021027
UMLS CUI [3,4]
C0205430
UMLS CUI [3,5]
C2347804
Contraindications and precautions for further doses
Description

Contraindications and precautions for further doses

Alias
UMLS CUI-1
C1301624
UMLS CUI-2
C1517331
UMLS CUI-3
C0178602
UMLS CUI-4
C1517331
UMLS CUI-5
C1882442
UMLS CUI-6
C0178602
Anaphylactic reaction following the administration of vaccine(s).
Description

Anaphylactic reaction following the administration of vaccine(s).

Type de données

boolean

Alias
UMLS CUI [1,1]
C0002792
UMLS CUI [1,2]
C0332282
UMLS CUI [1,3]
C0042196
Known hypersensitivity to any component of the vaccine, or subjects having shown signs of hypersensitivity after previous administration of diphtheria, tetanus, pertussis, HB, Hib or meningococcal vaccines.
Description

Hypersensitivity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C0042210
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0020517
UMLS CUI [2,3]
C0012546
UMLS CUI [2,4]
C0042210
UMLS CUI [3,1]
C0262926
UMLS CUI [3,2]
C0020517
UMLS CUI [3,3]
C0305062
UMLS CUI [4,1]
C0262926
UMLS CUI [4,2]
C0020517
UMLS CUI [4,3]
C0058773
UMLS CUI [5,1]
C0262926
UMLS CUI [5,2]
C0020517
UMLS CUI [5,3]
C0031237
UMLS CUI [6,1]
C0262926
UMLS CUI [6,2]
C0020517
UMLS CUI [6,3]
C0012559
UMLS CUI [7,1]
C0262926
UMLS CUI [7,2]
C0020517
UMLS CUI [7,3]
C2240392
UMLS CUI [8,1]
C0262926
UMLS CUI [8,2]
C0020517
UMLS CUI [8,3]
C2352428
UMLS CUI [9,1]
C0262926
UMLS CUI [9,2]
C0020517
UMLS CUI [9,3]
C0700144
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
Description

Immunosuppressive or immunodeficient condition

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0020962
UMLS CUI [1,3]
C0221099
UMLS CUI [2,1]
C0011900
UMLS CUI [2,2]
C0019693
UMLS CUI [3,1]
C0332147
UMLS CUI [3,2]
C0020962
UMLS CUI [3,3]
C0221099
UMLS CUI [4,1]
C0332147
UMLS CUI [4,2]
C0019693
Acute disease at the time of vaccination. (Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness, i.e., axillary or oral temperature < 37.5°C/rectal temperature < 38°C).
Description

The following AEs constitute contraindications to administration of the study vaccines at that point in time; if any one of these AEs occurs at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any adverse event

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001314
UMLS CUI [1,2]
C0205081
UMLS CUI [1,3]
C0205420
UMLS CUI [1,4]
C2368628
UMLS CUI [2,1]
C0001314
UMLS CUI [2,2]
C0205420
UMLS CUI [2,3]
C2368628
UMLS CUI [2,4]
C0205082
Axillary or oral temperature ≥ 37.5°C/rectal temperature ≥ 38°C at the time of vaccination.
Description

The following AEs constitute contraindications to administration of the study vaccines at that point in time; if any one of these AEs occurs at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any adverse event

Type de données

boolean

Alias
UMLS CUI [1,1]
C0437737
UMLS CUI [1,2]
C1531924
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C0042196
UMLS CUI [2,1]
C0437737
UMLS CUI [2,2]
C0489749
UMLS CUI [2,3]
C0347984
UMLS CUI [2,4]
C0042196
UMLS CUI [3,1]
C1532216
UMLS CUI [3,2]
C0437737
UMLS CUI [3,3]
C0347984
UMLS CUI [3,4]
C0042196
UMLS CUI [4,1]
C0015967
UMLS CUI [4,2]
C0347984
UMLS CUI [4,3]
C0042196
DEMOGRAPHICS
Description

DEMOGRAPHICS

Alias
UMLS CUI-1
C1698647
Subject number
Description

Previous study : 759346/009 (DTPwHB/HIBMenACTT009)

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Date of birth
Description

Birth date

Type de données

date

Alias
UMLS CUI [1]
C0421451
Gender
Description

Gender

Type de données

text

Alias
UMLS CUI [1]
C0079399
Race
Description

Race

Type de données

text

Alias
UMLS CUI [1]
C0034510
If Other, please specify
Description

Specify Other

Type de données

text

Alias
UMLS CUI [1,1]
C0034510
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C2348235
Has the subject had any serious adverse event since the end of the primary phase and before the start of this booster vaccination ?
Description

If Yes → Specify number of SAE’s : |__|__| and → Check SAE form(s) have been submitted to GSK Biologicals

Type de données

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C4511973
UMLS CUI [1,3]
C2347804
UMLS CUI [2,1]
C1519255
UMLS CUI [2,2]
C0332185
PRE-VACCINATION ASSESSMENT
Description

PRE-VACCINATION ASSESSMENT

Alias
UMLS CUI-1
C0042196
UMLS CUI-2
C0220825
UMLS CUI-3
C0332152
Temperature
Description

Temperature

Type de données

float

Unités de mesure
  • °C
Alias
UMLS CUI [1]
C0005903
°C
Route
Description

preferrably axillary

Type de données

text

Alias
UMLS CUI [1,1]
C0886414
UMLS CUI [1,2]
C0449444
THROAT SWAB (for subject’s parents/guardians)
Description

THROAT SWAB (for subject’s parents/guardians)

Alias
UMLS CUI-1
C0439056
UMLS CUI-3
C0030551
UMLS CUI-4
C0023226
Will the throat swab be taken from the same person as at Visit 1, 2 or 4?
Description

Will the throat swab be taken from the same person as at Visit 1, 2 or 4 ?

Type de données

boolean

Alias
UMLS CUI [1,1]
C0730255
UMLS CUI [1,2]
C1552089
UMLS CUI [1,3]
C0445247
UMLS CUI [1,4]
C4727054
I certify that Informed Consent has been obtained prior to any study procedure :
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0150312
Informed Consent Date:
Description

Informed Consent Date

Type de données

date

Alias
UMLS CUI [1]
C2985782
Has a throat swab been taken ?
Description

Has a throat swab been taken ?

Type de données

boolean

Alias
UMLS CUI [1,1]
C0730255
UMLS CUI [1,2]
C1272695
Please complete only if different from visit date:
Description

Date

Type de données

date

Alias
UMLS CUI [1]
C0011008
THROAT SWAB (for subject)
Description

THROAT SWAB (for subject)

Alias
UMLS CUI-1
C0439056
UMLS CUI-3
C0681850
Has a throat swab been taken ?
Description

throat swab

Type de données

boolean

Alias
UMLS CUI [1,1]
C0730255
UMLS CUI [1,2]
C1272695
Please complete only if different from visit date:
Description

Date

Type de données

date

Alias
UMLS CUI [1]
C0011008
VACCINE ADMINISTRATION
Description

VACCINE ADMINISTRATION

Alias
UMLS CUI-1
C2368628
Has the commercial measles vaccine been administered ?
Description

measles vaccine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025010
UMLS CUI [1,2]
C2368628
UMLS CUI [1,3]
C1272695
Has the commercial yellow fever vaccine been administered ?
Description

yellow fever vaccine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0301508
UMLS CUI [1,2]
C1272695
UMLS CUI [1,3]
C2368628
Retour au début de la page

Similar models

Visit 5 ( Month 7.5)

1 Formulaires
  1. StudyEvent: ODM
    1. Visit 5 ( Month 7.5)
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Center
Item
Center
integer
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item Group
ELIMINATION CRITERIA DURING THE STUDY
C0680251 (UMLS CUI-1)
C0347984 (UMLS CUI-2)
C0008976 (UMLS CUI-3)
Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) during the study period.
Item
Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) during the study period.
boolean
C0013230 (UMLS CUI [1,1])
C4723751 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,4])
C2347804 (UMLS CUI [1,5])
C0013230 (UMLS CUI [2,1])
C4723751 (UMLS CUI [2,2])
C0304229 (UMLS CUI [2,3])
C0042196 (UMLS CUI [2,4])
C0347984 (UMLS CUI [2,5])
C2347804 (UMLS CUI [2,6])
Chronic immunosuppressants or other immunemodifying drugs during the study period
Item
Chronic administration (defined as more than 14 days) of immunosuppressants or other immunemodifying drugs during the study period.
boolean
C0021081 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C2347804 (UMLS CUI [1,4])
C0005525 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0347984 (UMLS CUI [2,3])
C2347804 (UMLS CUI [2,4])
C0332300 (UMLS CUI [3,1])
C2065041 (UMLS CUI [3,2])
C0332300 (UMLS CUI [4,1])
C2064827 (UMLS CUI [4,2])
Unplanned vaccination
Item
Administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before the first dose of vaccine(s) and ending 30 days after the last dose of vaccine(s) with the exception of OPV.
boolean
C0042196 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C4511973 (UMLS CUI [1,3])
C2347804 (UMLS CUI [1,4])
C2348563 (UMLS CUI [1,5])
C4698437 (UMLS CUI [1,6])
C0332300 (UMLS CUI [2,1])
C0032375 (UMLS CUI [2,2])
Administration of a meningococcal vaccine
Item
Administration of a meningococcal vaccine not foreseen by the study protocol during the entire study period.
boolean
C2368628 (UMLS CUI [1,1])
C0700144 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C2347804 (UMLS CUI [1,4])
C2348563 (UMLS CUI [1,5])
C4698437 (UMLS CUI [1,6])
Administration of immunoglobulins and/or any blood products during the study period.
Item
Administration of immunoglobulins and/or any blood products during the study period.
boolean
C1533734 (UMLS CUI [1,1])
C0021027 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
C1533734 (UMLS CUI [2,1])
C0456388 (UMLS CUI [2,2])
C2347804 (UMLS CUI [2,3])
C1533734 (UMLS CUI [3,1])
C0456388 (UMLS CUI [3,2])
C0021027 (UMLS CUI [3,3])
C0205430 (UMLS CUI [3,4])
C2347804 (UMLS CUI [3,5])
Item Group
Contraindications and precautions for further doses
C1301624 (UMLS CUI-1)
C1517331 (UMLS CUI-2)
C0178602 (UMLS CUI-3)
C1517331 (UMLS CUI-4)
C1882442 (UMLS CUI-5)
C0178602 (UMLS CUI-6)
Anaphylactic reaction following the administration of vaccine(s).
Item
Anaphylactic reaction following the administration of vaccine(s).
boolean
C0002792 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
Hypersensitivity
Item
Known hypersensitivity to any component of the vaccine, or subjects having shown signs of hypersensitivity after previous administration of diphtheria, tetanus, pertussis, HB, Hib or meningococcal vaccines.
boolean
C0020517 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
C0262926 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
C0012546 (UMLS CUI [2,3])
C0042210 (UMLS CUI [2,4])
C0262926 (UMLS CUI [3,1])
C0020517 (UMLS CUI [3,2])
C0305062 (UMLS CUI [3,3])
C0262926 (UMLS CUI [4,1])
C0020517 (UMLS CUI [4,2])
C0058773 (UMLS CUI [4,3])
C0262926 (UMLS CUI [5,1])
C0020517 (UMLS CUI [5,2])
C0031237 (UMLS CUI [5,3])
C0262926 (UMLS CUI [6,1])
C0020517 (UMLS CUI [6,2])
C0012559 (UMLS CUI [6,3])
C0262926 (UMLS CUI [7,1])
C0020517 (UMLS CUI [7,2])
C2240392 (UMLS CUI [7,3])
C0262926 (UMLS CUI [8,1])
C0020517 (UMLS CUI [8,2])
C2352428 (UMLS CUI [8,3])
C0262926 (UMLS CUI [9,1])
C0020517 (UMLS CUI [9,2])
C0700144 (UMLS CUI [9,3])
Immunosuppressive or immunodeficient condition
Item
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
boolean
C0011900 (UMLS CUI [1,1])
C0020962 (UMLS CUI [1,2])
C0221099 (UMLS CUI [1,3])
C0011900 (UMLS CUI [2,1])
C0019693 (UMLS CUI [2,2])
C0332147 (UMLS CUI [3,1])
C0020962 (UMLS CUI [3,2])
C0221099 (UMLS CUI [3,3])
C0332147 (UMLS CUI [4,1])
C0019693 (UMLS CUI [4,2])
Acute disease at the time of vaccination
Item
Acute disease at the time of vaccination. (Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness, i.e., axillary or oral temperature < 37.5°C/rectal temperature < 38°C).
boolean
C0001314 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0205420 (UMLS CUI [1,3])
C2368628 (UMLS CUI [1,4])
C0001314 (UMLS CUI [2,1])
C0205420 (UMLS CUI [2,2])
C2368628 (UMLS CUI [2,3])
C0205082 (UMLS CUI [2,4])
Axillary or oral temperature ≥ 37.5°C/rectal temperature ≥ 38°C at the time of vaccination.
Item
Axillary or oral temperature ≥ 37.5°C/rectal temperature ≥ 38°C at the time of vaccination.
boolean
C0437737 (UMLS CUI [1,1])
C1531924 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,4])
C0437737 (UMLS CUI [2,1])
C0489749 (UMLS CUI [2,2])
C0347984 (UMLS CUI [2,3])
C0042196 (UMLS CUI [2,4])
C1532216 (UMLS CUI [3,1])
C0437737 (UMLS CUI [3,2])
C0347984 (UMLS CUI [3,3])
C0042196 (UMLS CUI [3,4])
C0015967 (UMLS CUI [4,1])
C0347984 (UMLS CUI [4,2])
C0042196 (UMLS CUI [4,3])
Item Group
DEMOGRAPHICS
C1698647 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Birth date
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
text
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (1)
CL Item
Female (2)
Item
Race
text
C0034510 (UMLS CUI [1])
Race
Code List
Race
CL Item
Black (1)
CL Item
Arabic/North African (2)
CL Item
White/Caucasian (3)
CL Item
East & South East Asian (4)
CL Item
South Asian (5)
CL Item
Other (6)
Specify Other
Item
If Other, please specify
text
C0034510 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Serious adverse event
Item
Has the subject had any serious adverse event since the end of the primary phase and before the start of this booster vaccination ?
boolean
C1519255 (UMLS CUI [1,1])
C4511973 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
C1519255 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
Item Group
PRE-VACCINATION ASSESSMENT
C0042196 (UMLS CUI-1)
C0220825 (UMLS CUI-2)
C0332152 (UMLS CUI-3)
Temperature
Item
Temperature
float
C0005903 (UMLS CUI [1])
Item
Route
text
C0886414 (UMLS CUI [1,1])
C0449444 (UMLS CUI [1,2])
Route
Code List
Route
CL Item
Axillary (1)
CL Item
Rectal (2)
Item Group
THROAT SWAB (for subject’s parents/guardians)
C0439056 (UMLS CUI-1)
C0030551 (UMLS CUI-3)
C0023226 (UMLS CUI-4)
Will the throat swab be taken from the same person as at Visit 1, 2 or 4 ?
Item
Will the throat swab be taken from the same person as at Visit 1, 2 or 4?
boolean
C0730255 (UMLS CUI [1,1])
C1552089 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,3])
C4727054 (UMLS CUI [1,4])
Informed Consent
Item
I certify that Informed Consent has been obtained prior to any study procedure :
boolean
C0021430 (UMLS CUI [1,1])
C0150312 (UMLS CUI [1,2])
Informed Consent Date
Item
Informed Consent Date:
date
C2985782 (UMLS CUI [1])
Has a throat swab been taken ?
Item
Has a throat swab been taken ?
boolean
C0730255 (UMLS CUI [1,1])
C1272695 (UMLS CUI [1,2])
Date
Item
Please complete only if different from visit date:
date
C0011008 (UMLS CUI [1])
Item Group
THROAT SWAB (for subject)
C0439056 (UMLS CUI-1)
C0681850 (UMLS CUI-3)
throat swab
Item
Has a throat swab been taken ?
boolean
C0730255 (UMLS CUI [1,1])
C1272695 (UMLS CUI [1,2])
Date
Item
Please complete only if different from visit date:
date
C0011008 (UMLS CUI [1])
Item Group
VACCINE ADMINISTRATION
C2368628 (UMLS CUI-1)
measles vaccine
Item
Has the commercial measles vaccine been administered ?
boolean
C0025010 (UMLS CUI [1,1])
C2368628 (UMLS CUI [1,2])
C1272695 (UMLS CUI [1,3])
yellow fever vaccine
Item
Has the commercial yellow fever vaccine been administered ?
boolean
C0301508 (UMLS CUI [1,1])
C1272695 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial